Fundraising Fox

William Dai

Investor

Managing Partner at ShangBay Capital LLC

Palo Alto, California

Writes $100K – $5M checks Β· typically $1.5M

FoundedApostleNeuroVasc

About

William Dai is the Founding Managing Partner of ShangBay Capital, an early-stage medtech-focused VC firm he started in 2015. Before founding the firm, he spent over 20 years in corporate finance, M&A, and capital markets in Asia and the U.S., serving as CFO of ShangPharma, Nepstar Corporation, Microport Scientific Corporation, and Boston Scientific China, and beginning his career as a Finance Manager at Ford Motor Company. He holds an MBA with a finance emphasis from Michigan State University.

Invests in

Medical Devices

Experience

  1. Luminopia Inc.Board Membercurrent2022 β€” presentBoston, Massachusetts, United States
  2. ShangBay CapitalFounding Managing Partnercurrent2015 β€” presentPalo Alto, California, United States
  3. ShangBay CapitalFounding Managing Partnercurrent2015 β€” presentPalo Alto, California, United States
  4. YorLabsBoard Membercurrent2021 β€” presentOregon, United States
  5. Laplace InterventionalBoard Membercurrent2021 β€” presentMinneapolis, Minnesota, United States
  6. SetPoint MedicalBoard Observercurrent2022 β€” presentSanta Clarita, California, United States
  7. SetPoint MedicalBoard Member2020 β€” 2022United States
  8. Aqua MedicalBoard Membercurrent2020 β€” presentSanta Ana, California, United States
  9. FemDx MedicalBoard Membercurrent2020 β€” presentSanta Clara County, California, United States
  10. Huma.AIBoard Membercurrent2019 β€” presentLos Altos, California
  11. Meditrina IncBoard Membercurrent2019 β€” presentSan Jose, California
  12. Corinth MedicalBoard Membercurrent2019 β€” presentCupertino, California
  13. Apostle, IncBoard Membercurrent2017 β€” presentSanta Clara, California
  14. Emboline, Inc.Board Member2018 β€” 2021
  15. NeuroVasc Technologies Inc.Board Member2015 β€” 2019Laguna Hills, California
  16. ARRINEX, INC.Board Member2016 β€” 2019Redwood City, California
  17. Ceribell, IncBoard Member2015 β€” 2017Mountain View, California
  18. ShangPharma Corporation (NYSE: SHP)CFO2011 β€” 2014
  19. NepstarCFO2009 β€” 2010
  20. MicroPort Scientific (HK: 00853)CFO2006 β€” 2008

Education

  1. Michigan State University - The Eli Broad Graduate School of ManagementMBA, Finance1991 β€” 1993

Skills & more

Financial Modeling74Venture Capital58Mergers10Corporate Finance33Corporate Development25International Business9Financial Reporting6Sarbanes-Oxley Act5Mergers & Acquisitions48Private Equity16Valuation18Acquisition Integration16
+10 moreRestructuringInvestor RelationsM&A experienceDue DiligenceBusiness StrategyFinanceBusiness DevelopmentBusiness PlanningStrategyStrategic Planning

From William's professional profile.

Shared employers

Investments

Board seats

ApostleAqua MedicalArrinexCorinth MedtechEarly Bird MedicalEmbolineFemDxLaplace InterventionalLuminopiaMeditrinaNeuroVascSetPoint MedicalYorlabs

Per the firm's website.

Colleagues at ShangBay Capital LLC